Robert Blaustein

Insider Reports History

Location
Boulder, CO
Signature
John R. Moore, by POA from Robert Blaustein
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert Blaustein:

Company Role Class Num Shares Value Price $ Report Date Ownership
Edgewise Therapeutics, Inc. Chief Development Officer Restricted Stock Units 17,500 $821,241 $27.37 12 Aug 2025 Direct
Edgewise Therapeutics, Inc. Chief Development Officer Stock Options (Right to buy) 105,000 12 Aug 2025 Direct

Insider Reports Filed by Robert Blaustein

Symbol Company Period Transactions Value $ Form Type Role Filing Time
EWTX Edgewise Therapeutics, Inc. 12 Aug 2025 2 $0 4 Chief Development Officer 14 Aug 2025, 19:44
EWTX Edgewise Therapeutics, Inc. 21 Jan 2025 2 $0 4 Chief Development Officer 23 Jan 2025, 19:56
EWTX Edgewise Therapeutics, Inc. 21 Jan 2025 0 $0 3 Chief Development Officer 23 Jan 2025, 19:56